Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Iridex Cp (IRIX)

Iridex Cp (IRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Iridex Cp 1212 Terra Bella Avenue Mountain View CA 94043 USA

www.iridex.com P: 650-940-4700 F: 650-940-4710

Description:

IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.

Key Statistics

Overview:

Market Capitalization, $K 47,784
Enterprise Value, $K 40,754
Shares Outstanding, K 16,253
Annual Sales, $ 51,870 K
Annual Net Income, $ -9,570 K
Last Quarter Sales, $ 12,460 K
Last Quarter Net Income, $ -2,960 K
EBIT, $ -10,000 K
EBITDA, $ -8,900 K
60-Month Beta 0.82
% of Insider Shareholders 6.20%
% of Institutional Shareholders 20.10%
Float, K 15,245
% Float 93.80%
Short Volume Ratio 0.15

Growth:

1-Year Return 29.52%
3-Year Return -65.81%
5-Year Return -44.94%
5-Year Revenue Growth 21.76%
5-Year Earnings Growth 43.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.18 on 03/26/24
Latest Earnings Date 05/09/24
Earnings Per Share ttm -0.59
EPS Growth vs. Prev Qtr -63.64%
EPS Growth vs. Prev Year -157.14%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IRIX Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -75.18%
Return-on-Assets % -25.99%
Profit Margin % -18.45%
Debt/Equity 0.00
Price/Sales 0.95
Price/Cash Flow N/A
Price/Book 4.90
Book Value/Share 0.59
Interest Coverage -0.62
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar